Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
Impact of mild traumatic brain injury on cingulate functions.
Michel BF, Sambuchi N, Vogt BA. Michel BF, et al. Handb Clin Neurol. 2019;166:151-162. doi: 10.1016/B978-0-444-64196-0.00010-8. Handb Clin Neurol. 2019. PMID: 31731910 Review.
Primary low-intensity "invisible injury" is solely detectable at ultrastructural levels. Over the long term, mTBI is not a static event but a progressive injury, increasing risk of neurodegenerative diseases. ...
Primary low-intensity "invisible injury" is solely detectable at ultrastructural levels. Over the long term, mTBI is not a static eve …
Visual and visuospatial short-term memory in mild cognitive impairment and Alzheimer disease: role of attention.
Alescio-Lautier B, Michel BF, Herrera C, Elahmadi A, Chambon C, Touzet C, Paban V. Alescio-Lautier B, et al. Among authors: michel bf. Neuropsychologia. 2007 Apr 9;45(8):1948-60. doi: 10.1016/j.neuropsychologia.2006.04.033. Epub 2007 Feb 1. Neuropsychologia. 2007. PMID: 17275041
Second, to determine the relative contribution of attentional impairment on the performance of MCI and AD patients, we tested the influence of a distractor in the interval between the memory image and recognition tests. Results showed that visuospatial short-term deficits …
Second, to determine the relative contribution of attentional impairment on the performance of MCI and AD patients, we tested the influence …
[Long-term treatment of Alzheimer's disease: followup of a cohort of 255 patients treated with lacrine for four years].
Michel BF, Estadieu MC, Gueriot C, Berthezène P, Allain H, Bongrand MC, Bonnefoy B, Bourrin JC, Chaix L, Graa K, Lejeune A, Messana M, Pras P, Ribiere J, Rihet P, Timon-David P, Tintignac A, Vincent S, Verdier JM, Gastaut JL. Michel BF, et al. Rev Neurol (Paris). 2001 Nov;157(11 Pt 1):1365-75. Rev Neurol (Paris). 2001. PMID: 11924005 French.
We found 85 hepatic (33 percent), 79 cholinergic (31 percent), 31 (12 percent) neuropsychiatric and 72 general (28 percent) side effects. In term of drug efficacy we observed a global decline of 2.5 MMS points during the first year and 2 MMS points between W52 and W156. .. …
We found 85 hepatic (33 percent), 79 cholinergic (31 percent), 31 (12 percent) neuropsychiatric and 72 general (28 percent) side effects. In …
[Balance sheet of tolerance-efficacy on the use of tacrine in 100 cases of Alzheimer's disease].
Estadieu MC, Machou C, Berthezène P, Pastor MJ, Angelini B, Bohor M, Bongrand MC, Timon-David P, Gastaut JL, Allain H, Michel BF. Estadieu MC, et al. Among authors: michel bf. Therapie. 1998 Jan-Feb;53(1):67-76. Therapie. 1998. PMID: 9773102 Clinical Trial. French.
We conclude that there is a necessity for close follow-up of tacrine-treated patients, and that globally at 8 months there is an improvement or a stabilization in 40 per cent of patients and long term (at one year) a stabilizing effect on AD patients....
We conclude that there is a necessity for close follow-up of tacrine-treated patients, and that globally at 8 months there is an improvement …
[Memory clinics: long-term follow-up].
Michel BF, Pasquier F, Mahieux F. Michel BF, et al. Therapie. 1997 Sep-Oct;52(5):481-2. Therapie. 1997. PMID: 9501581 French.